286 related articles for article (PubMed ID: 33508235)
1. Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model.
Patrizi C; Llado M; Benati D; Iodice C; Marrocco E; Guarascio R; Surace EM; Cheetham ME; Auricchio A; Recchia A
Am J Hum Genet; 2021 Feb; 108(2):295-308. PubMed ID: 33508235
[TBL] [Abstract][Full Text] [Related]
2. Retinal degeneration in humanized mice expressing mutant rhodopsin under the control of the endogenous murine promoter.
Liu X; Jia R; Meng X; Li Y; Yang L
Exp Eye Res; 2022 Feb; 215():108893. PubMed ID: 34919893
[TBL] [Abstract][Full Text] [Related]
3. Mutation-independent rescue of a novel mouse model of Retinitis Pigmentosa.
Greenwald DL; Cashman SM; Kumar-Singh R
Gene Ther; 2013 Apr; 20(4):425-34. PubMed ID: 22809998
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/SaCas9-based gene editing rescues photoreceptor degeneration throughout a rhodopsin-associated autosomal dominant retinitis pigmentosa mouse model.
Du W; Li J; Tang X; Yu W; Zhao M
Exp Biol Med (Maywood); 2023 Oct; 248(20):1818-1828. PubMed ID: 37837380
[TBL] [Abstract][Full Text] [Related]
5. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa.
Mao H; James T; Schwein A; Shabashvili AE; Hauswirth WW; Gorbatyuk MS; Lewin AS
Hum Gene Ther; 2011 May; 22(5):567-75. PubMed ID: 21126223
[TBL] [Abstract][Full Text] [Related]
6. In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa.
Bakondi B; Lv W; Lu B; Jones MK; Tsai Y; Kim KJ; Levy R; Akhtar AA; Breunig JJ; Svendsen CN; Wang S
Mol Ther; 2016 Mar; 24(3):556-63. PubMed ID: 26666451
[TBL] [Abstract][Full Text] [Related]
7. Allele-specific gene-editing approach for vision loss restoration in
Liu X; Qiao J; Jia R; Zhang F; Meng X; Li Y; Yang L
Elife; 2023 Jun; 12():. PubMed ID: 37272616
[TBL] [Abstract][Full Text] [Related]
8. Long-term rescue of retinal structure and function by rhodopsin RNA replacement with a single adeno-associated viral vector in P23H RHO transgenic mice.
Mao H; Gorbatyuk MS; Rossmiller B; Hauswirth WW; Lewin AS
Hum Gene Ther; 2012 Apr; 23(4):356-66. PubMed ID: 22289036
[TBL] [Abstract][Full Text] [Related]
9. Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine Model.
Orlans HO; Barnard AR; PatrĂcio MI; McClements ME; MacLaren RE
Hum Gene Ther; 2020 Jul; 31(13-14):730-742. PubMed ID: 32394751
[TBL] [Abstract][Full Text] [Related]
10. CRISPR DNA Base Editing Strategies for Treating Retinitis Pigmentosa Caused by Mutations in
Kaukonen M; McClements ME; MacLaren RE
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893064
[TBL] [Abstract][Full Text] [Related]
11. Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78.
Gorbatyuk MS; Knox T; LaVail MM; Gorbatyuk OS; Noorwez SM; Hauswirth WW; Lin JH; Muzyczka N; Lewin AS
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5961-6. PubMed ID: 20231467
[TBL] [Abstract][Full Text] [Related]
12. Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa.
Meng D; Ragi SD; Tsang SH
Mol Ther; 2020 Oct; 28(10):2139-2149. PubMed ID: 32882181
[TBL] [Abstract][Full Text] [Related]
13. Wheel running exercise protects against retinal degeneration in the I307N rhodopsin mouse model of inducible autosomal dominant retinitis pigmentosa.
Zhang X; Girardot PE; Sellers JT; Li Y; Wang J; Chrenek MA; Wu W; Skelton H; Nickerson JM; Pardue MT; Boatright JH
Mol Vis; 2019; 25():462-476. PubMed ID: 31523123
[TBL] [Abstract][Full Text] [Related]
14. Binocular benefit following monocular subretinal AAV injection in a mouse model of autosomal dominant retinitis pigmentosa (adRP).
Ahmed CM; Massengill MT; Ildefonso CJ; Jalligampala A; Zhu P; Li H; Patel AP; McCall MA; Lewin AS
Vision Res; 2023 May; 206():108189. PubMed ID: 36773475
[TBL] [Abstract][Full Text] [Related]
15. CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa.
Wu WH; Tsai YT; Huang IW; Cheng CH; Hsu CW; Cui X; Ryu J; Quinn PMJ; Caruso SM; Lin CS; Tsang SH
Mol Ther; 2022 Apr; 30(4):1407-1420. PubMed ID: 35150888
[TBL] [Abstract][Full Text] [Related]
16. Gene delivery of wild-type rhodopsin rescues retinal function in an autosomal dominant retinitis pigmentosa mouse model.
Mao H; Gorbatyuk MS; Hauswirth WW; Lewin AS
Adv Exp Med Biol; 2012; 723():199-205. PubMed ID: 22183334
[TBL] [Abstract][Full Text] [Related]
17. CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis Pigmentosa.
Burnight ER; Wiley LA; Mullin NK; Adur MK; Lang MJ; Cranston CM; Jiao C; Russell SR; Sohn EH; Han IC; Ross JW; Stone EM; Mullins RF; Tucker BA
CRISPR J; 2023 Dec; 6(6):502-513. PubMed ID: 38108516
[TBL] [Abstract][Full Text] [Related]
18. Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector.
Cideciyan AV; Sudharsan R; Dufour VL; Massengill MT; Iwabe S; Swider M; Lisi B; Sumaroka A; Marinho LF; Appelbaum T; Rossmiller B; Hauswirth WW; Jacobson SG; Lewin AS; Aguirre GD; Beltran WA
Proc Natl Acad Sci U S A; 2018 Sep; 115(36):E8547-E8556. PubMed ID: 30127005
[TBL] [Abstract][Full Text] [Related]
19. Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa.
Orlans HO; McClements ME; Barnard AR; Martinez-Fernandez de la Camara C; MacLaren RE
Nat Commun; 2021 Aug; 12(1):4934. PubMed ID: 34400638
[TBL] [Abstract][Full Text] [Related]
20. Challenging Safety and Efficacy of Retinal Gene Therapies by Retinogenesis.
Marrocco E; Maritato R; Botta S; Esposito M; Surace EM
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]